Cargando…
Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
Ablative approaches using radioiodine are increasingly proposed for the treatment of Graves′ disease (GD) but their ophthalmologic and biological autoimmune responses remain controversial and data concerning clinical and biochemical outcomes are limited. The aim of this study was to evaluate thyroid...
Autores principales: | Nwatsock, J. F., Taieb, D., Tessonnier, L., Mancini, J., Dong-A-Zok, F., Mundler, O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425234/ https://www.ncbi.nlm.nih.gov/pubmed/22942775 http://dx.doi.org/10.4103/1450-1147.98731 |
Ejemplares similares
-
Late Recurrences of Thyroid Carcinoma 24 Years after a Complete Remission: When Monitoring Should be Stopped?
por: Nwatsock, Joseph Francis, et al.
Publicado: (2012) -
Heath-related quality of life in thyroid cancer patients following radioiodine ablation
por: Taïeb, David, et al.
Publicado: (2011) -
A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001) -
Worsening of pretibial myxedema following radioiodine treatment for hyperthyroid Graves’ disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2023) -
Observational Study on Outcomes after Radioiodine Ablation in Hyperthyroid Patients
por: Pamnani, Harsha, et al.
Publicado: (2022)